Home » Evaluating Camu Camu With Ipilimumab and Nivolumab in mRCC

Evaluating Camu Camu With Ipilimumab and Nivolumab in mRCC

by Regina Barragan-Carrillo, MD | Aug 14, 2024 | Articles | 0 Comments